Lynn A. Tetrault - May 18, 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
May 18, 2022
Transactions value $
$24,238
Form type
4
Date filed
5/20/2022, 05:08 PM
Previous filing
Oct 13, 2021
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $24.2K +3.33K +9.32% $7.27 39.1K May 18, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Options Exercise $0 -3.33K -100% $0.00* 0 May 18, 2022 Common Stock 3.33K $7.27 Direct F1
holding NEO Stock Option (Right to Buy) 1.51K May 18, 2022 Common Stock 1.51K $11.60 Direct
holding NEO Stock Option (Right to Buy) 2.14K May 18, 2022 Common Stock 2.14K $22.52 Direct
holding NEO Stock Option (Right to Buy) 3.45K May 18, 2022 Common Stock 3.45K $28.54 Direct
holding NEO Stock Option (Right to Buy) 3.71K May 18, 2022 Common Stock 3.71K $40.90 Direct
holding NEO Stock Option (Right to Buy) 972 May 18, 2022 Common Stock 972 $41.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 25, 2017, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.